开云app官网登录入口网页版-官方正版

#代偿性肝硬化#

20篇内容 | 1273人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2171549, encodeId=696a21e1549ea, content=<a href='/topic/show?id=779a5362677' target=_blank style='color:#2F92EE;'>#慢性肝病#</a> <a href='/topic/show?id=937f53428df' target=_blank style='color:#2F92EE;'>#慢加急性肝衰竭#</a> <a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=临床研究｜慢加急性肝衰竭：基于起病表现的新型临床分型特征及预后分析, objectType=article, longId=802658, objectId=3c18802658a6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PTE4SCK.jpg, objectUrl=/article/show_article.do?id=3c18802658a6, replyNumber=0, likeNumber=83, createdTime=2023-11-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3c18802658a6, moduleTitle=临床研究｜慢加急性肝衰竭：基于起病表现的新型临床分型特征及预后分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3c18802658a6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2077570, encodeId=667c20e75703c, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=AJG: 熊去氧胆酸可以降低原发性胆汁性胆管炎伴代偿性肝硬化的死亡率, objectType=article, longId=217778, objectId=c74021e77820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c74021e77820, replyNumber=0, likeNumber=74, createdTime=2021-11-30, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c74021e77820, moduleTitle=AJG: 熊去氧胆酸可以降低原发性胆汁性胆管炎伴代偿性肝硬化的死亡率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c74021e77820)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077569, encodeId=16c820e75699b, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=J Hepatology: β受体阻滞剂的短期血流动力学影响会对失代偿性肝硬化患者的生存产生负面作用, objectType=article, longId=201792, objectId=2c6d201e9206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c6d201e9206, replyNumber=0, likeNumber=61, createdTime=2021-03-16, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c6d201e9206, moduleTitle=J Hepatology: β受体阻滞剂的短期血流动力学影响会对失代偿性肝硬化患者的生存产生负面作用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2c6d201e9206)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077568, encodeId=722e20e7568a8, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Diagn Pathol：Treg/Th17比值可作为预测失代偿性肝硬化的潜在标志物, objectType=article, longId=201611, objectId=f47a201611b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f47a201611b5, replyNumber=0, likeNumber=63, createdTime=2020-10-24, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f47a201611b5, moduleTitle=Diagn Pathol：Treg/Th17比值可作为预测失代偿性肝硬化的潜在标志物, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f47a201611b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077567, encodeId=980920e756755, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Dig Liver Dis：代偿性肝硬化患者中胃蛋白酶和抵抗素是细菌感染的更好标志 , objectType=article, longId=190035, objectId=f28a19003512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28a19003512, replyNumber=0, likeNumber=68, createdTime=2020-06-27, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28a19003512, moduleTitle=Dig Liver Dis：代偿性肝硬化患者中胃蛋白酶和抵抗素是细菌感染的更好标志 , moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f28a19003512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077565, encodeId=21ef20e7565d2, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后, objectType=article, longId=164757, objectId=7be1164e5777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be1164e5777, replyNumber=0, likeNumber=73, createdTime=2019-10-26, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be1164e5777, moduleTitle=Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7be1164e5777)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077566, encodeId=980720e756635, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=J Gastroenterology：治疗代偿性腹水可减轻肌肉减少症并改善失代偿性肝硬化患者的生存率, objectType=article, longId=187607, objectId=e94e18e6078b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e94e18e6078b, replyNumber=0, likeNumber=105, createdTime=2021-01-06, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e94e18e6078b, moduleTitle=J Gastroenterology：治疗代偿性腹水可减轻肌肉减少症并改善失代偿性肝硬化患者的生存率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e94e18e6078b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077563, encodeId=d98420e7563c0, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=J Hepatol：3级肥胖是失代偿性肝硬化患者发生慢加急性肝衰竭的危险因素, objectType=article, longId=147942, objectId=c24b14e94268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c24b14e94268, replyNumber=0, likeNumber=82, createdTime=2018-11-22, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c24b14e94268, moduleTitle=J Hepatol：3级肥胖是失代偿性肝硬化患者发生慢加急性肝衰竭的危险因素, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c24b14e94268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077562, encodeId=d69e20e7562e9, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Hepatology：监测肝细胞癌对代偿性肝硬化患者生存的影响, objectType=article, longId=145511, objectId=55d2145511ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55d2145511ce, replyNumber=0, likeNumber=76, createdTime=2018-09-16, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55d2145511ce, moduleTitle=Hepatology：监测肝细胞癌对代偿性肝硬化患者生存的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=55d2145511ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077556, encodeId=c29f20e7556a2, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Hepatology：EBR/GZR联合SOF治疗HCV基因3型代偿性肝硬化患者初治和经治患者疗效良好, objectType=article, longId=132753, objectId=3721132e538f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3721132e538f, replyNumber=0, likeNumber=72, createdTime=2018-09-09, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3721132e538f, moduleTitle=Hepatology：EBR/GZR联合SOF治疗HCV基因3型代偿性肝硬化患者初治和经治患者疗效良好, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3721132e538f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077557, encodeId=65b720e7557d8, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=EASL临床实践指南：失代偿性肝硬化患者的管理, objectType=article, longId=135570, objectId=c1481355e018, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1481355e018, replyNumber=0, likeNumber=80, createdTime=2018-08-19, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1481355e018, moduleTitle=EASL临床实践指南：失代偿性肝硬化患者的管理, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c1481355e018)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077564, encodeId=74b620e756499, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Gastroenterology：Simtuzumab对非酒精性脂肪性肝炎引起的桥接纤维化或代偿性肝硬化治疗无效, objectType=article, longId=151110, objectId=e6d0151110ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d0151110ee, replyNumber=0, likeNumber=60, createdTime=2019-01-09, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d0151110ee, moduleTitle=Gastroenterology：Simtuzumab对非酒精性脂肪性肝炎引起的桥接纤维化或代偿性肝硬化治疗无效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e6d0151110ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077559, encodeId=5a4420e755961, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Hepatology：慢加急性肝功能衰竭(ACLF)和失代偿性肝硬化(INR)患者凝血功能衰竭, objectType=article, longId=140002, objectId=ed09140002c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed09140002c7, replyNumber=0, likeNumber=66, createdTime=2018-09-11, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed09140002c7, moduleTitle=Hepatology：慢加急性肝功能衰竭(ACLF)和失代偿性肝硬化(INR)患者凝血功能衰竭, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ed09140002c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077558, encodeId=8f5320e755804, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率, objectType=article, longId=139713, objectId=53d8139e13a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53d8139e13a9, replyNumber=0, likeNumber=105, createdTime=2018-08-23, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53d8139e13a9, moduleTitle=Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=53d8139e13a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077555, encodeId=f7cc20e755505, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Liver Int：急性肾损伤而败血症是侵入性操作后失代偿性肝硬化患者出血的独立预测因子, objectType=article, longId=129514, objectId=bc5f12951479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc5f12951479, replyNumber=0, likeNumber=117, createdTime=2018-12-25, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc5f12951479, moduleTitle=Liver Int：急性肾损伤而败血症是侵入性操作后失代偿性肝硬化患者出血的独立预测因子, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bc5f12951479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077561, encodeId=87c720e756169, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Liver Int：高丙种球蛋白血症是疾病进展、肝细胞癌和代偿性肝硬化患者死亡的重要预测因素, objectType=article, longId=145289, objectId=18db14528919, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18db14528919, replyNumber=0, likeNumber=76, createdTime=2018-09-18, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18db14528919, moduleTitle=Liver Int：高丙种球蛋白血症是疾病进展、肝细胞癌和代偿性肝硬化患者死亡的重要预测因素, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=18db14528919)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077554, encodeId=6c4720e75545e, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=J Gastroenterol Hepatol：移植hUCMSCs治疗方法对失代偿性肝硬化患者可能是一个合适的选择, objectType=article, longId=128011, objectId=986b1280116e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=986b1280116e, replyNumber=0, likeNumber=92, createdTime=2019-01-04, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986b1280116e, moduleTitle=J Gastroenterol Hepatol：移植hUCMSCs治疗方法对失代偿性肝硬化患者可能是一个合适的选择, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=986b1280116e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077560, encodeId=56ee20e7560a9, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Liver Int：治疗26周时的肝脏硬度可以预测HBV相关代偿性肝硬化患者的2年预后结果, objectType=article, longId=140302, objectId=29f2140302e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29f2140302e7, replyNumber=0, likeNumber=92, createdTime=2018-08-14, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29f2140302e7, moduleTitle=Liver Int：治疗26周时的肝脏硬度可以预测HBV相关代偿性肝硬化患者的2年预后结果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=29f2140302e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077553, encodeId=612620e7553fc, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=Liver Int：高γ-球蛋白血症是代偿性肝硬化患者疾病进展、HCC发生和死亡的预测因素, objectType=article, longId=123104, objectId=4df31231048e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4df31231048e, replyNumber=0, likeNumber=99, createdTime=2018-08-26, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4df31231048e, moduleTitle=Liver Int：高γ-球蛋白血症是代偿性肝硬化患者疾病进展、HCC发生和死亡的预测因素, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4df31231048e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077552, encodeId=279e20e7552ec, content=<a href='/topic/show?id=94c7253e768' target=_blank style='color:#2F92EE;'>#代偿性肝硬化#</a>, objectTitle=J Hepatol：生存率不降反升卡维地洛对失代偿性肝硬化和腹水患者无害, objectType=article, longId=106945, objectId=27ad10694558, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27ad10694558, replyNumber=0, likeNumber=79, createdTime=2018-04-26, rootId=0, userName=ms5106640509429053, userId=d37d2500154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27ad10694558, moduleTitle=J Hepatol：生存率不降反升卡维地洛对失代偿性肝硬化和腹水患者无害, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=27ad10694558)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

代偿性肝硬化

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肝病# #慢加急性肝衰竭# #代偿性肝硬化#

临床研究｜慢加急性肝衰竭：基于起病表现的新型临床分型特征及预后分析

2023-11-28发表于上海

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

AJG: 熊去氧胆酸可以降低原发性胆汁性胆管炎伴代偿性肝硬化的死亡率

2021-11-30

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

J Hepatology: β受体阻滞剂的短期血流动力学影响会对失代偿性肝硬化患者的生存产生负面作用

2021-03-16

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Diagn Pathol：Treg/Th17比值可作为预测失代偿性肝硬化的潜在标志物

2020-10-24

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Dig Liver Dis：代偿性肝硬化患者中胃蛋白酶和抵抗素是细菌感染的更好标志

2020-06-27

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Lancet：代偿性肝硬化伴门脉高压症患者使用β阻滞剂可改善预后

2019-10-26

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

J Gastroenterology：治疗代偿性腹水可减轻肌肉减少症并改善失代偿性肝硬化患者的生存率

2021-01-06

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

J Hepatol：3级肥胖是失代偿性肝硬化患者发生慢加急性肝衰竭的危险因素

2018-11-22

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Hepatology：监测肝细胞癌对代偿性肝硬化患者生存的影响

2018-09-16

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Hepatology：EBR/GZR联合SOF治疗HCV基因3型代偿性肝硬化患者初治和经治患者疗效良好

2018-09-09

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

EASL临床实践指南：失代偿性肝硬化患者的管理

2018-08-19

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Gastroenterology：Simtuzumab对非酒精性脂肪性肝炎引起的桥接纤维化或代偿性肝硬化治疗无效

2019-01-09

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Hepatology：慢加急性肝功能衰竭(ACLF)和失代偿性肝硬化(INR)患者凝血功能衰竭

2018-09-11

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Lancet：人白蛋白治疗可提高失代偿性肝硬化患者的生存率

2018-08-23

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Liver Int：急性肾损伤而败血症是侵入性操作后失代偿性肝硬化患者出血的独立预测因子

2018-12-25

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Liver Int：高丙种球蛋白血症是疾病进展、肝细胞癌和代偿性肝硬化患者死亡的重要预测因素

2018-09-18

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

J Gastroenterol Hepatol：移植hUCMSCs治疗方法对失代偿性肝硬化患者可能是一个合适的选择

2019-01-04

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Liver Int：治疗26周时的肝脏硬度可以预测HBV相关代偿性肝硬化患者的2年预后结果

2018-08-14

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

Liver Int：高γ-球蛋白血症是代偿性肝硬化患者疾病进展、HCC发生和死亡的预测因素

2018-08-26

ms5106640509429053 (审核中...)

前往app查看评论内容

#代偿性肝硬化#

J Hepatol：生存率不降反升卡维地洛对失代偿性肝硬化和腹水患者无害

2018-04-26

科室
- - 订阅+
  - 更多科室
工具
服务